The anchor round
Paras Healthcare Ltd, which operates hospitals under the Paras Health brand, has garnered ₹652.5 crore from anchor investors ahead of its ₹1,450-crore initial public offering, according to exchange circulars reported by The Hindu BusinessLine on October 20, 2026.
The company allotted 94,15,584 equity shares to 39 funds at ₹693 apiece — the top end of its price band. Anchor bidding took place on October 19, the day before the news broke.
Who bought in
The anchor book drew a mix of domestic and global institutional heavyweights: SBI Mutual Fund, HDFC Mutual Fund, ICICI Prudential Mutual Fund, Kotak Mutual Fund, and WhiteOak Capital on the domestic side, plus sovereign and global names including the Abu Dhabi Investment Authority (ADIA), BlackRock, and Eastspring Investments.
A book that blends India's largest mutual fund houses with sovereign wealth and global asset managers is typically read as a strong quality signal — it suggests the deal has been scrubbed by long-only institutions that plan to hold, not flip.
The IPO terms
The ₹1,450 crore public issue opens for subscription on October 21 and closes on October 23, 2026, with listing expected around October 28 on the BSE and NSE.
Key terms:
- Price band: ₹660–₹693 per share
- Fresh issue: ₹500 crore of new equity
- Offer for sale (OFS): ₹950 crore by existing shareholders — promoter Dharminder Kumar Nagar and investor Commelina Ltd
- Minimum lot: 21 shares (₹14,553 at the upper end)
- Book-running lead managers: JM Financial, BofA Securities India, and Nuvama Wealth Management
Notably, the Gurugram-based company trimmed the issue size from the ₹1,800 crore it had planned earlier — a reduction that often signals either market-condition pragmatism or a negotiated valuation with anchor investors. About 34% of the total issue is fresh capital; the rest exits go to the promoter and the existing investor.
How the money will be used
The ₹500 crore fresh issue is earmarked primarily for debt repayment — repaying or prepaying outstanding loans, including borrowings at its wholly owned subsidiary Plus Medicare Hospitals Private Limited, which operates a hospital in Srinagar — with the remainder for general corporate purposes.
The business: eight hospitals across tier-2 and tier-3 India
Paras Healthcare operates a network of eight multi-specialty hospitals with cumulative bed capacity of about 2,211 beds, concentrated in tier-2 and tier-3 cities across North India: Gurugram and Panchkula (Haryana), Patna and Darbhanga (Bihar), Kanpur (Uttar Pradesh), Udaipur (Rajasthan), Ranchi (Jharkhand), and Srinagar (Jammu and Kashmir). The company plans to expand with new facilities in Gurugram and Ludhiana, targeting total bed capacity of 3,011 beds by March 2028.
The chain is backed by private equity investors Creador and 360 ONE, which invested ahead of the IPO.
Context: India's healthcare IPO wave
Paras is part of a broader wave of Indian healthcare listings. Investors have been keen on hospital chains because of structurally rising demand — India's aging population, growing insurance penetration, and tier-2/3 markets where organized hospital capacity is still scarce. But valuations have become a flashpoint: hospital stocks have traded at rich multiples, and debt-heavy balance sheets make IPO proceeds earmarked for deleveraging a harder sell than growth capex. The anchor line-up here suggests institutional comfort with Paras's pricing at ₹693.
Why it matters for founders
Paras's playbook offers three lessons. First, a reduced issue size (₹1,800 crore planned → ₹1,450 crore) shows that recalibrating valuation expectations before the anchor round can produce a strong book — don't chase a headline number and risk a weak subscription. Second, landing a mixed domestic-sovereign-global anchor book is the strongest pre-listing validation a founder can show: it de-risks the public subscription for retail and HNI bidders. Third, use-of-proceeds clarity matters — debt repayment is honest but unsexy, so founders should pair it with a visible growth story (here, the bed-expansion target of 3,011 by March 2028).
Why it matters for investors
The anchor book at the top of the band, led by India's biggest mutual funds plus ADIA and BlackRock, de-risks the price discovery but also concentrates expectations at ₹693. Key diligence questions: whether the deleveraging actually improves margins and cash flows post-listing, how quickly the new-bed expansion comes online, and how Paras's per-bed economics compare with listed hospital peers. Anchor strength is a signal, not a guarantee — it reflects institutional views today, not the stock's trajectory after the lock-in period ends.
Angeled.com connects founders with investors.
Sources: The Hindu BusinessLine, MFNewsDaily, Drug Today Online
Read Next
Inovalon to Acquire DrFirst, Uniting Healthcare Data With Prescribing Workflows
Oura to Acquire Counsel Health for $625 Million, Putting a Doctor Behind the Ring
Anthropic Files Updated IPO Prospectus Aiming at a $1.4 Trillion Valuation
Archrock to Acquire HiVolt Energy for Up to $450 Million
Barrick Mining Files to Spin Off and List Its North American Gold Business
What a $1.4 Trillion Anthropic IPO Would Mean for Founders



